Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults

<b>Background/Objectives:</b> Individuals with immunocompromising conditions are at high risk of developing severe respiratory syncytial virus (RSV) illness. This phase 3, single-arm study assessed the safety and immunogenicity of the bivalent RSV prefusion F protein−based (RSVpreF) 120-µg vaccine i...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Natalia Castillo Almeida, Lalitha Parameswaran, Elliot N. DeHaan, Hayley Wyper, Farah Rahman, Qin Jiang, Wen Li, Michael Patton, Maria Maddalena Lino, Zaynah Majid-Mahomed, Elissa Malkin, Matthew Davis, William J. Towner, Kapil Saharia, Kumar Ilangovan, Elena Kalinina, David Cooper, Kena A. Swanson, Annaliesa S. Anderson, Alejandra Gurtman, Iona Munjal
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2025-03-01
Serie:	Vaccines
Ämnen:	RSVpreF RSV immunogenicity safety immunocompromised renally impaired
Länkar:	https://www.mdpi.com/2076-393X/13/3/328
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!